Abstract
I. Introduction
Diabetes is gradually emerging as a major public health challenge. According to the International Diabetes Federation (IDF), the overall cost assessment for the global prevention and treatment of diabetes will run up to $490 billion by 2030. The prevalence of diabetes is higher in men than in women and diabetes prevalence across the world appears to be increase in the proportion of people greater than 65 years of age (Mohan et al., 2007) . Diabetes mellitus has attained a pandemic form. Diabetes is a metabolic disorder of carbohydrate, fat and protein resulting from defects in insulin secretion, insulin action or both (Diabetes Care, 2010) . Due to the failure of the modern medicine to address this issues without it inherent problems which result as toxicity to target organ, there arose the need to turn back to nature using herbals which seems more potential with less toxic effect, hence a search by different communities on the possibilities of sourcing antidiabetics from their surrounding.
S.nitida is a plant in the family of Celastraceae. Salacia is a climbing shrub distributed in Sri-Lanka, South-West India, Thialand, Philippines, Java, South Africa and Southeastern part of Nigeria. The plant is locally called "enyimocha" in Ibo and "akorkor in Ogoni. The stem, leaves, rhizomes and roots are harvested from the wild plant and they contain several bioactive metabolites. It flowers fruits throughout the year depending on the humidity of the soil. In the traditional system of medicine, the plants of this genus are being used as acrid, bitter, thermogenic, astringent, anodyne, anti-inflammatory, depurative, emmenagogue, vulnerary, liver tonic and stomachic. They are useful in vitiates conditions of vata, diabetes, hemorrhoids, inflammation, leucorrhoea, leprosy, skin diseases, amenorrhoea, dysmenorrhoea, wounds, ulcers, hyperhydrosis, hepatopathy, dyspepsia, flatulence, colic and spermatorrhoea. Herbal tea containing Salaciareticulata gives a significant reduction in fasting plasma glucose level, glycatedhaemoglobin and body mass index suggesting the use of S.reticulata diet for individuals with mild type 2 diabetes (Kajimotoet al., 2000). The powdered root bark of S.oblonga is used to treat inflammations.
S.nitida is marketed as a starch blocker suggesting that it might help to reduce the body weight. The ethanolic extracts of the roots of S.nitida is used in the treatment of malaria in the southeastern part of Nigeria (Ogbonnaet al., 2008) . Therefore this study was set to ascertain the antidiabetic and cytoprotective effect of ethanolic root extract of salacianitida on alloxan-induced diabetic rat.
Animal Care and Handling
The animals used for the study were 30Wistaralbino rats of both sexes weighing 150-200g procured from the animal house of Department of Experimental Pharmacology& Toxicology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Rivers State. They were grouped based on their body weight into five groups of six animals each. They were housed in spacious cages and maintained in standard laboratory conditions. They were fed with standard pelletized feed (manufactured by Premier Feed Mill Co. Ltd) and were allowed water ad libitium. Animal ethics and proper handling methods were strictly adhered to. The bedding of the cages (saw dust) was changed daily and the cages washed and disinfected every other day.
Diabetes Induction Using Alloxan
Diabetes mellitus was induced in a batch of normoglycemic albino rats using alloxan monohydrate. After acclimatization period and grouping of the animals, the animals were then fasted for 18 hours over night to prepare them for induction. Group 1 was used as control. Group 2, 3, 4, and 5 were made diabetic by single IP injection of alloxan monohydrate (120mg/kg) and served as diabetic control, treatment and standard groups respectively. Rats that exhibited plasma glucose levels >250mg/dl, 7 days after administration of alloxan were included in the study. Treatment for diabetes (S.nitida extract 750mg/kg and 1500mg/kg orally) and glibenclamide was initiated from the 7 th day of post alloxan administration.
Evaluation of Antidiabetic Activity
Seven days after alloxan injections, the hyperglycemic rats (blood glucose level > 250mg/kg) were selected for the anti-diabetic study. The animals were divided into various groups for treatment. The different groups are as follows; -Group 1-non-induced/non-induced rats(normal control) -Group 2-induced/non-treated rats ( toxic control) -Group 3-induced/750mg/kg of S.nitida -Group 4-induced/1500mg/kg of S.nitida -Group 5-induced/5mg/kg glibenclamide. These treatment protocols were followed and performed daily for 21 days. Blood glucose samples were collected by tail tipping method from the overnight fasted rats. The blood glucose level was determined by the glucose strip method, using a glucometer.
Oral Glucose Tolerance Test
The oral glucose tolerance test was performed in overnight fasted normal, diabetic and treated rats on the 21 st day of the treatment. Glucose (2g/kg) was given orally and the blood glucose level was measured at 0, 30, 60, 90 and 120 minutes after administration of the glucose.
Histopathological Analysis
The organs of the animals were harvested afterwards by anaesthetizing using light ether anaesthetic, the extracted organs; liver, kidney and pancreas were weighed to obtain the absolute organ weight, fixed in 10% formaldehyde and taken for histological analysis.After 72 hours, the organs were dehydrated in graded alcohol, cleared in xylene and embedded in paraffin. The processing of the harvested tissues was done by an autotechnician, the slides were mounted and stained with hematoxylin and eosin (H&E). The stained sections were morphologically evaluated and pictures of the slides were taken and recorded for comparism. DOI: 10.9790/3008-1201038793 www.iosrjournals.org 89 | Page
Statistical Analysis
Analysis using Anova software was carried out to examine the statistical significance of differences in the mean levels of the various parameters and biomarkers between the control and test groups. Table 1shows theeffect of different doses of the plant extract and glibenclamide on BGL of alloxan induced diabetic rat indicating a dosed dependent significant percentage reduction in blood glucose levels after 14 and 21 days of treatment with the highest reduction of BGL noted when the standard drug GBM was used. Table 2 shows the effect of different doses of the plant extract and GBM on the body weight of alloxan induced diabetic and treated rats. The table shows significant dose dependent increase in the body weight of the diabetic rats treated with the plant extracts and the standard drug. Table 3 shows a significant time and dose dependent reduction in blood glucose levels of diabetic rats treated with both plant extract and glibenclamide compared to the untreated rats. Untreated diabetic rats died after 30 minutes because of low glucose tolerance
III. Results
Resultof the effect of different doses of the plant extract and GBM on the feed and fluid intake, absolute and relative weight of organs of alloxan induced diabetic rat is shown in table 4. The table shows a significant decrease in feed and fluid intake of diabetic rats treated with the plant extract compared to the untreated diabetic rats. 
IV. Discussion
The management of diabetes with medications devoid of any side effects is still a major challenge to the medical system. This concern has led to an increase demand for natural products with antihyperglycemic activity, and fewer side effects. In this study, the results obtained suggest that the ethanolic extract of the root of Salacianitida exhibits dose dependent anti-diabetic property and tissue protective effects. Acute toxicity testing of the ethanolic extract of roots of Salacianitida suggests that the lethal dose is greater than 5000mg/kg as there were no incidence of abnormalities, gross lesions, body weight changes and mortality observed in the albino rats when the dose of 5000mg/kg plant extract was administered. The roots of this plant can be said to be relatively safe (Lorke, 1983) .
The phytochemical screening of the ethanolic extractof Salacianitida root revealed the presence of alkaloids, cardiac glycosides, saponins, tannins, flavonoids, phenolic compounds, terpenoids, phlobotannins and carbohydrates. Some of these phytocomponents may cause hypoglycaemic effect in diabetic rats. Studies have shown that such biological activityhypoglycaemic effect might manifest due to the presence of flavonoids, alkaloids, steroids and quinones (Sanders et al., 2001; Ghosh and Konishi, 2007) . Also, saponins have been reported to exhibit hypoglycaemic activity which may have inhibitory effects on liver (Nakashima et al., 1993) .
The ethanolic extract of Salacianitidaroot exhibited a dose dependent hypoglycaemic property as shown in table Table 1 . The result shows that the ethanolic extract of the plant acted on the blood glucose, exhibiting potential glucose tolerance effect and is concordance with the report of Singh (2011) . This is reflected in the significant decrease in the blood glucose levels of the diabetic rats treated with S. . Plant fibres may also interfere with carbohydrate absorption, thereby affecting blood glucose (Subramoniam, 1996) . Natural products having antidiabetic potential act through the following mechanisms:-Drugs acting like insulin (insulinomimetics); drugs acting on insulin secreting beta cells (secretagogues); drugs modifying glucose utilization; drugs regenerating and/or repairing pancreatic beta cells; drugs preventing pathological conversion of starch to glucose by inhibition of beta-galactosidase, alpha-glucosidase and alpha-amylase; drugs preventing oxidative stress that is possibly involved in pancreatic beta cell dysfunction found in diabetes (Jarald, 2008) . Diabetic rats exhibited significant decrease in body weight; however, treatment with S.nitida root extracts restored the body weights to near normal levels. Weight gains were lesser in diabetic rats treated with S.nitidathan in those treated with glibenclamide. Improvement of body weight of the diabetic rats treated with the plant extract may be due to the antidiabetogenic effect of S.nitida, as type 1 diabetic condition is associated with loss of body weight.
The supplementation of S.nitidaimproved the glucose tolerance in the fasted treated rats (Table 3) . From the table, diabetic rats treated with the plant extracts showed a significant reduction in glucose induced hyperglycaemia to near normal levels, while all untreated diabetic rats died at 60 minutes suggesting their low tolerance to glucose.
An evaluation of the absolute organ (Pancreas, Kidney and Liver) weight of the alloxaninduced diabetic rats (Table 4 ) revealed a significant decrease in the weight of the organs of rats treated with ethanolic root extract of S.nitida and glibenclamide compared to the weights of the organ of the untreated rats. The alteration in overall organ-body weight ratio is an indication of impairment in the normal functioning of the organs.
Also, the feed and fluid intake of diabetic rats was affected by the ethanolic root extract of Salacianitida on the feed and fluid intake on diabetic rats (Table 4 ). The table shows a dose dependent significant decrease in the feed and fluid intake of diabetic rats treated with S.nitidacompared with the untreated diabetic rats. However a slight but not significant increase was observed in the feed and fluid intake levels when compared to the control. Improvement in the feed and fluid intake of the diabetic rats treated with the plant extract further supports the antidiabetogenic effect of S.nitida in the management of diabetes. The reduction in feed and fluid intake in diabetic rats treated with 5mg/kg glibenclamide was slightly higher than the group treated with 1500mg/kg S.nitida.
Because appropriate morphological studies are useful for the anatomical localization of action of toxin (Sagaret al., 2010), functional studies in toxicology was coupled with appropriate histological studies. The photomicrograph of the pancreas of the untreated diabetic rats shows degeneration of the pancreatic islet cells (figure 1b). This degeneration of the pancreatic islet cells will cause a rise in blood glucose level and poor utilization of glucose leading to hyperglycemia. The photomicrograph of the pancreas of treated diabetic rats (figures 1c, 1d and 1e) shows that treatments with the extracts and glibenclamide caused a regeneration of the pancreatic islet cells. Comparing figures 1c and 1d, it is observed that when a higher concentration (1500mg/kg) of the extract was given, a greater restorative effect was shown on the islet cells than when the lower dose (750mg/kg) was used.
The photomicrographs of the kidney of the control (non-diabetic group) in figure 2a show that the kidney of the non-diabetic rats were normal, showing numerous glomerulus, renal tubules and blood vessels. However, the photomicrograph of the untreated diabetic rats (figure 2b) shows severe haemorrhage and distortion of renal tubules. The different doses of the extracts 750mg/kg (figure 2c) and 1500mg/kg (figure 2d) showed normal histological features, with the restorations close to normal when 1500mg/kg dose of extract is used.
The photomicrograph of the liver of non-diabetic rats (figure 3a) shows normal hepatocytes, central vein and sinusoids as expected. While the photomicrograph of the liver of untreated diabetic rats show histological changes in the liver. Alloxan induced inflammations as a collection of inflammatory cells were seen together with sinusoidal haemorrhage and hepatocyte injury (fig 3b) . However, administering 750mg/kg dose of the extract reduced the inflammation slightly (figure 3c), while a 1500mg/kg dose resulted in more pronounced reduced inflammation and no haemorrhage (figure 3d). Treatment with 5mg/kg of glibenclamide resulted in restoration to a normal liver histology (figure 3e). Results obtained in the histology studies suggest that S.nitida root extract is non-toxic to the kidney and liver at all doses used and under a prolonged usage.
Conclusion: in conclusion, results from both the histological and the toxicological studies all support the use of the roots of Salacianitida in the management of diabetes. Mean ± SEM (n=6) *=p < 0.05, significantly different compared to the diabetic untreated group. I.C = diabetic induce; GBM = Glibenclamide 
